Back
ESC Premium Access

Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drug treatment: a prospective multicenter study in China

Session: Poster Session 4 - Hypertension, risk factors and treatment
Topic: Treatment
Speaker: Doctor W. Zhang (Beijing, CN)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Wei Li Zhang

National Center for Cardiovascular Diseases, Beijing (China)
0 follower

9 more presentations in this session

The active dynamic observation of patients with arterial hypertension is the key to improving of blood pressure control

Speaker: Doctor I. Starodubtseva (Voronezh, RU)

Access
Abstract
Slides
Thumbnail

Relationship between QTc-interval and diastolic dysfunction in African patients with hypertension.

Speaker: Professor A. Mbakwem (Lagos, NG)

Access
Abstract
Thumbnail

Fifteen years changes of uric acid level and prevalence of hyperuricemia in hypertensive subjects

Speaker: Doctor H. Takase (Hamamatsu, JP)

Access
Abstract
Thumbnail

Effect of nebivolol on gender-different efficacy and safety in Korean patients with hypertension: result from BENEFIT-KOREA study

Speaker: Professor K. Cho (Busan, KR)

Access
Abstract
Thumbnail

Impact of cognitive decline on therapeutic adherence in elderly hypertensive patients

Speaker: Doctor F. Abcha (Ariana, TN)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 4 - Hypertension, risk factors and treatment

Speakers: Doctor W. Zhang, Doctor I. Starodubtseva, Professor A. Mbakwem, Doctor H. Takase, Professor K. Cho...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb